Session: Renal Artery Denervation is Approved and Has a Fee Code - This is Only the Start of a Potentially Massive Opportunity for Procedural Growth That IR Must Be a Part Of
Renal Artery Denervation by Focused Ultrasound and Radiofrequency Ablation
Head vascular and Oncological Interventional Radiology Hopital Europeen Georges Pompidou, France
Approximately 30% of US adults have hypertension, less than 50% overall are well controlled. Two renal artery denervation (RDN) devices for treatment of hypertension are now FDA approved. Tips on practice building and RDN procedural technique will be presented. In addition to hypertension, sympathetic overactivity has been shown to contribute to insulin resistance, metabolic syndrome, obstructive sleep apnea, heart failure and renal disease. Applications of denervation to a broad variety of common conditions will be described, most of which are ideally suited to IR skill sets.
.jpg)
